Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle.
Castration initiates extensive apoptosis of the secretory epithelial cells lining the ducts of the rat ventral prostate, resulting in the striking regression of this male sexual accessory tissue. We had previously described the paradox of finding similar cascades of gene activity (c-fos greater than c-myc greater than hsp-70) induced during the early period of ventral prostate regression and during the regrowth of the ventral prostate gland initiated by testosterone replenishment. This common pattern of protooncogene expression during periods of predominant cellular apoptosis or proliferation caused us to examine further the possibility that the two cellular events occur through identical early molecular pathways. In the present study we demonstrate that apoptotic prostate epithelial cells incorporate bromodeoxyuridine into nuclear high-molecular-weight DNA prior to nuclear DNA fragmentation. The DNA synthetic activity occurs in coordination with a massive induction of proliferative cell nuclear antigen, a proliferation marker, in the nuclei of androgen-deprived prostatic epithelial cells. Moreover, this activity is also associated with the increased expression of mRNA encoding p53, a suppressor gene well known as a cell cycle-blocking agent. Our data indicate that quiescent (G0) prostate epithelial cells undergo apoptosis due to two sequential events initiated by testosterone depletion. The first event is the active reentry of these cells into the cell cycle. The second event is the apoptotic destruction resulting from the inability of the differentiated cells to successfully complete this cycle.
Colombel
M
M
Department of Urology, Columbia University, College of Physicians and Surgeons, New York, New York 10032.
Olsson
C A
CA
Ng
P Y
PY
Buttyan
R
R
D000818:Animals; D015139:Blotting, Southern; D001973:Bromodeoxyuridine / Q000493:pharmacokinetics; D016923:Cell Death / Q000235:genetics / Q000502:physiology*; D004247:DNA / Q000096:biosynthesis*; D008297:Male; D009687:Nuclear Proteins / Q000032:analysis*; D009691:Nucleic Acid Denaturation; D009919:Orchiectomy; D018809:Proliferating Cell Nuclear Antigen; D011467:Prostate / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D051381:Rats; D011919:Rats, Inbred Strains; D016196:S Phase / Q000235:genetics / Q000502:physiology*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis / Q000235:genetics
D009687:Nuclear Proteins; D018809:Proliferating Cell Nuclear Antigen; D016159:Tumor Suppressor Protein p53; D004247:DNA; D001973:Bromodeoxyuridine